BH4 bioavailability is a key determinant of eNOS function and NO production21 and deficient endothelial cell BH4 biosynthesis, or loss of BH4 by oxidation, leads to eNOS uncoupling, vascular dysfunction, and hypertension. This evidence concerns the gene NOS3 and hypertensive disorder.